Next-generation sequencing in breast cancer: first take home messages.

Auteurs : Desmedt C, Voet T, Sotiriou C, Campbell PJ
Jaar : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pagina's : 597-604

Dissecting the heterogeneity of triple-negative breast cancer.

Auteurs : Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA, Ellis P, Di Leo A, Baselga J, Sotiriou C, Piccart-Gebhart M
Jaar : 2012
Journal : J. Clin. Oncol.
Volume : 30(15)
Pagina's : 1879-87

Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Auteurs : Pradeep CR, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart-Gebhart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y
Jaar : 2012
Journal : Oncogene
Volume : 31(31)
Pagina's : 3569-83

Expression profiling in: WHO Classification of Tumours of the Breast, (Chapter 1: Invasive Breast Carcinoma: introduction and general features) Chapter book : (IARC, 4th edition, 2012)

Auteurs : Van de Vijver MJ, Hayes D, Perou C, Sotiriou C, Reis LO
Jaar : 2012
Journal : Book
Volume : 4th edition
Pagina's : 29-31

Préface, in de Cremoux P. (Ed): Signatures moléculaires des cancers. L’Innovation thérapeutique en cancérologie - Chapter book (John Libey Eurotext, 2012)

Auteurs : Sotiriou C
Jaar : 2012
Journal : Book
Volume : 6
Pagina's : VII-VIII

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Auteurs : Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, van de Vijver M, Viale G, Loi S, Reis-Filho JS
Jaar : 2012
Journal : Ann Oncol
Volume : 23(12)
Pagina's : 2997-3006

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Auteurs : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Jaar : 2012
Journal : Breast
Volume : 21(1)
Pagina's : 20-6

The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study.

Auteurs : Azim HA, Botteri E, Renne G, Dell orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart-Gebhart M, Goldhirsch A, Viale G, Peccatori F
Jaar : 2012
Journal : Acta oncol (Stockholm)
Volume : 51(5)
Pagina's : 653-61

Introduction to Gene Expression Profiling In Breast Cancer in “Breast Surgical techniques and Interdisciplinary Management”, (TEXTBOOK Dirbas FM. & Scott-Conner C.E.H. Editors (Springer, 2011 - 440 pages).

Auteurs : Dirbas FM, Sotiriou C
Jaar : 2011
Journal : Book
Volume : -
Pagina's : -

Outils génomiques pouvant aider au choix thérapeutique des cancers du sein – Analyse in « Cancer du Sein : compte-rendu du 12ème Cours francophone supérieur de cancérologie – (TEXTBOOK : Nice, St-Paul de Vence, Janvier 19-22, 2011 » Namer M., Héry M.

Auteurs : Ignatiadis M, Sotiriou C
Jaar : 2011
Journal : Book
Volume : -
Pagina's : 311-16

HER2-positive circulating tumor cells in breast cancer.

Auteurs : Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C, Metallo J, Kheddoumi N, Singhal SK, Michiels S, Veys I, Rossari J, Larsimont D, Carly B, Pestrin M, Bessi S, Buxant F, Liebens F, Piccart-Gebhart M, Sotiriou C
Jaar : 2011
Journal : PLoS One
Volume : 6(1)
Pagina's : e15624

Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).

Auteurs : Altintas S, Toussaint J, Durbecq V, Lambein K, Huizing MT, Larsimont D, Van Marck E, Vermorken JB, Tjalma WA, Sotiriou C
Jaar : 2011
Journal : Breast J
Volume : 17(4)
Pagina's : 343-51

Gene profiling assay and application: the predictive role in primary therapy.

Auteurs : Fumagalli D, Desmedt C, Ignatiadis M, Loi S, Piccart-Gebhart M, Sotiriou C
Jaar : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pagina's : 124-7

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response.

Auteurs : Li Q, Eklund AC, Birkbak NJ, Desmedt C, Haibe-Kains B, Sotiriou C, Symmans WF, Pusztai L, Brunak S, Richardson AL, Szallasi Z
Jaar : 2011
Journal : BMC Bioinformatics
Volume : 12(null)
Pagina's : 310

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Auteurs : Bedard PL, Singhal SK, Ignatiadis M, Bradbury I, Haibe-Kains B, Desmedt C, Loi S, Evans DB, Michiels S, Dixon JM, Miller WR, Piccart-Gebhart M, Sotiriou C
Jaar : 2011
Journal : Endocr Relat Cancer
Volume : 18(6)
Pagina's : 721-30

Multiple-input multiple-output causal strategies for gene selection.

Auteurs : Bontempi G, Haibe-Kains B, Desmedt C, Sotiriou C, Quackenbush J
Jaar : 2011
Journal : BMC Bioinformatics
Volume : 12(1)
Pagina's : 458

DNA methylation profiling reveals a predominant immune component in breast cancers.

Auteurs : Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart-Gebhart M, Sotiriou C, Fuks F
Jaar : 2011
Journal : EMBO Mol Med
Volume : 3(12)
Pagina's : 726-41

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Auteurs : Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G, Aglietta M, Gianni L, Miller WR, Untch M, Sotiriou C, Daidone M, Conte P, Kennedy D, Damia G, Petronini P, Di Cosimo S, Bruzzi P, Dowsett M, Desmedt C, Mansel RE, Olivetti L, Tondini C, Sapino A, Fenaroli P, Tortora G, Thorne H, Bertolini F, Ferrozzi F, Danova M, Tagliabue E, de Azambuja E, Makris A, Tampellini M, Dontu G
Jaar : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pagina's : 147-51

Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Auteurs : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Jaar : 2011
Journal : Breast
Volume : 20 Suppl 3
Pagina's : S20-7

HER2-overexpressing breast cancer: time for the cure with less chemotherapy?

Auteurs : Loi S, de Azambuja E, Pugliano L, Sotiriou C, Piccart-Gebhart M
Jaar : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pagina's : 547-58